WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Desvenlafaxine Succinate (Pristiq) in New York

Also known as: Pristiq

Find doctors, physicians, and healthcare providers who prescribe Desvenlafaxine Succinate in New York. This page lists the top prescribers of Desvenlafaxine Succinate based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Desvenlafaxine Succinate?

PRISTIQ is indicated for the treatment of adults with major depressive disorder (MDD) . PRISTIQ is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).

Total Claims in New York
28,550
4.9% of all Desvenlafaxine Succinate prescriptions nationwide
Total Beneficiaries in New York
1,071
Total Cost in New York
$2,318,283

Top Prescribers in NY(5+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Carlo BayrakdarianWhite Plains, NYPsychiatry46644$27,866
Alexander PinkusovichBrooklyn, NYPsychiatry46547$25,868
Richard BennettOrchard Park, NYPsychiatry33360$18,527
Anna PotashBrooklyn, NYPsychiatry25228$12,333
Scott HolbrookMarcy, NYNurse Practitioner20319$15,831
Loading more data in background...

Find Desvenlafaxine Succinate doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.